VCG & Associates is an independent strategic marketing and contract services provider specializing in working with emerging pharmaceutical, biotech and technology companies. New Pharmaceutical Strategies (NPS) provides consulting services and contract resources related to pharmaceutical product distribution and supply chain management.
Under the two-year agreement, NPS will focus on enhancing sales of Auriga’s products by expanding its position in the retail and drug wholesale marketplace. NPS will be responsible for all trade development, national accounts and supply chain initiatives on behalf of Auriga and in effect will function as the in-house trade team.
“The co-promotion agreement with NPS represents an ideal trade and distribution strategy for Aquoral and other products in our portfolio,” said Philip Pesin, CEO of Auriga.
“NPS’s experienced management team has excellent relationships with all classes of trade, giving Auriga significant opportunity to expand distribution of our Extendryl and Levall product lines. This, coupled with Auriga’s active development pipeline and plan to launch 15 new products, gives us even greater confidence in our ability to execute and achieve the goals set forth in our business plan.”